Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comparison of homologous and heterologous prime-boost immunizations combining MVA-vectored and plant-derived VP2 as a strategy against IBDV

18 Nov 2016

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Animal Disease Management and Epidemiology
Share to Vector-Borne Animal Diseases
Share to Virology and Viral Diseases

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 27876199
DOI: 10.1016/j.vaccine.2016.11.029

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comparison of homologous and heterologous prime-boost immunizations combining MVA-vectored and plant-derived VP2 as a strategy against IBDVPMID 27876199Read ↗

Genetic heterologous prime–boost vaccination strategies for improved systemic and mucosal immunitySemantic proximity Read ↗

A review of reverse vaccinology approaches for the development of vaccines against ticks and tick borne diseasesSemantic proximity Read ↗

Heterologous prime–boost vaccination with adenoviral vector and protein nanoparticles induces both Th1 and Th2 responses against Middle East respiratory syndrome coronavirusSemantic proximity Read ↗

Herpesvirus of Turkey Recombinant Viruses Expressing Infectious Bursal Disease Virus (IBDV) VP2 Immunogen Induce Protection against an IBDV Virulent Challenge in ChickensSemantic proximity Read ↗

Heterologous prime boost COVID 19 vaccinationSemantic proximity Read ↗

Heterologous prime–boost vaccination with ChAdOx1 nCoV-19 and BNT162b2Semantic proximity Read ↗

Protective efficacy of a DNA vaccine construct encoding the VP2 gene of infectious bursal disease and a truncated HSP70 of Mycobacterium tuberculosis in chickensSemantic proximity Read ↗

Development and large-scale use of recombinant VP2 vaccine for the prevention of infectious bursal disease of chickensSemantic proximity Read ↗

Humoral immune responses by prime-boost heterologous route immunizations with CTB-MPR649–684, a mucosal subunit HIV/AIDS vaccine candidateSemantic proximity Read ↗

Sequential use of Ad26-based vaccine regimens in NHP to induce immunity against different disease targetsSemantic proximity Read ↗

Reverse vaccinologySemantic proximity Read ↗

Vaccinal control of Marek's disease: Current challenges, and future strategies to maximize protectionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.